Display options
Cite
Roschewski M, Longo DL, Wilson WH. CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?. N Engl J Med. 2021;doi: 10.1056/NEJMe2118899.
Roschewski, M., Longo, D. L., & Wilson, W. H. (2021). CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?. The New England journal of medicine, . https://doi.org/10.1056/NEJMe2118899
Roschewski, Mark, et al. "CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?." The New England journal of medicine vol. (2021). doi: https://doi.org/10.1056/NEJMe2118899
Roschewski M, Longo DL, Wilson WH. CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?. N Engl J Med. 2021 Dec 14; doi: 10.1056/NEJMe2118899. Epub 2021 Dec 14. PMID: 34904797.
Copy Download .nbib Format: NLM
Share it on

N Engl J Med. 2021 Dec 14; doi: 10.1056/NEJMe2118899. Epub 2021 Dec 14.

CAR T-Cell Therapy for Large B-Cell Lymphoma - Who, When, and How?.

The New England journal of medicine

Mark Roschewski, Dan L Longo, Wyndham H Wilson

Affiliations

  1. From the Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD (M.R., W.H.W.).

PMID: 34904797 DOI: 10.1056/NEJMe2118899

[No abstract available.]

Publication Types